TCR² Therapeutics
Kevin Zikaras has an extensive background in clinical development operations, having worked for various pharmaceutical companies and medical centers. Kevin is currently serving as the Vice President of Clinical Development Operations at TCR² Therapeutics Inc., where Kevin has played a pivotal role in building various clinical functions. Prior to this, Kevin held roles such as Director of Clinical Development at Actinium Pharmaceuticals, Inc. and Clinical Protocol Manager at Bristol-Myers Squibb. Kevin holds an MBA from Cornell Johnson Graduate School of Management and has a strong educational background in healthcare leadership and regulatory affairs.
This person is not in any offices
TCR² Therapeutics
TCR² Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.